More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved PTC's ...

In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...

PTC Industries (PTCIL)’s Q2FY26 EBITDA recovered to INR 257mn (+21% YoY), after a dismal Q1, as we believe TARC EBITDA losses would have reduced and ATL performance has improved. EBITDA margin, at ...

PTC is selling off its IoT businesses, Kepware and ThingWorx, in order to hone its focus on SaaS and AI, according to CEO Neil Barua, as the conglomerate announced a sale of the operations to asset ...

Shares of PTC Industries rallied 5 per cent to ₹17,900 on the BSE in Monday’s intra-day trade after the company said it received a Purchase Order from Gas Turbine Research Establishment (GTRE), ...

Abstract: In the point-cloud-based place recognition area, the existing hybrid architectures combining both convolutional networks and transformers have shown promising performance. They mainly apply ...

NHPC is unwilling to sell its stake in the power trading joint venture although it had, while shelving its buyout plan, said power trading was not its core business. New Delhi: After NHPC Ltd dropped ...

PTC has evolved into an SaaS-driven industrial software leader with improved profitability, higher margins, and a stronger competitive moat. Growth has been heavily acquisition-driven, raising ...

PTC has announced a major expansion of its collaboration with Nvidia, integrating the computing company’s Omniverse technologies into its flagship Creo and Windchill platforms. The move, PTC said, ...

Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to PTC's 2025 Third Quarter Conference Call. [Operator Instructions] Following the presentation, the conference will be ...